抗耐药金黄色葡萄球菌新药的研究进展
作者：杨应虹;罗有福;李子成;
Author：
收稿日期： 年卷（期）页码：2010,25(04):-494-496
期刊名称：华西药学杂志
Journal Name：WEST CHINA JOURNAL OF PHARMACEUTICAL SCIENCES
关键字：金黄色葡萄球菌;耐药;细胞毒力因子;治疗药物
Key words：
基金项目：
中文摘要
综述治疗金黄色葡萄球菌感染疾病相关治疗药物的研究进展。
参考文献
[1]Kaszanyitzky EJ,Jánosi S,Somogyi P,et al.MRSA transmis-sion between cows and humans[J].Emerg Infect Dis,2007,13(4):630-632.
[2]钟灿,陈一强.耐甲氧西林金黄色葡萄球菌的耐药状况及治疗进展[J].国际内科学杂志,2008,35(9):555-559.
[3]李金钟,刘利平.金黄色葡萄球菌对万古霉素的耐药机制[J].国际检验医学杂志,2006,27(7):648-652.
[4]Kalia V,Miglani R,Purnapatre KP,et al.Mode of action of ranbezolid against Staphylococci and structural modeling studies of its interaction with ribosomes[J].Antimicrob Agents Chemoth-er,2009,53(4):1427-1433.
[5]Greer ND.Tigecycline(Tygacil):the first in the glycylcycline class of antibiotics[J].Baylor University Medical Center Pro-ceedings,2006,19(2):155-161.
[6]Bogdanovich T,Esel D,Kelly LM,et al.Antistaphylococcal activity of DX-619,a new des-F(6)-quinolone,compared to those of other agents[J].Antimicrob Agents Chemother,2005,49(8):3325-3333.
[7]Bhagwat SS,Mcghee P,Shick KK,et al.In vitro activity of quinolone WCK771against recent US hospital and community acquired Staphylococcus aureus pathogens with various resistance types[J].Antimicrob Agents Chemother,2009,53:811-813.
[8]Pace J,Levasseur P,Girard AM,et al.Antibacterial activity of NXL103(linopristin/flopristin),in vitro post-antibiotic effect,and spontaneous frequency of resistance[J].ECCMID,1102.
[9]Darouiche RO,Mansouri MD,Schneidkraut MJ,et al.Comparative efficacy of telavancin and vancomycin in preventing device-associ-ated colonization and infection by Staphylococcus aureus in rabbits[J].Antimicrob Agents Chemother,2009,53:2626-2628.
[10]Brown SD,Traczewski MM.Comparative in vitro antimicrobial activity of a new cephalosporin,ceftaroline,and determination of quality control ranges for MIC testing[J].Antimicrob Agents Chemother,2009,53:1271-1274.
[11]Koga T,Abe T,Inoue H,et al.In vitro and in vivo antibacterial activities of CS-023(RO4908463),a novel parenteral carbap-enem[J].Antimicrob Agents Chemother,2005,49(8):3239-3250.
[12]Koga T,Masuda N,Kakuta M,et al.Potent in vitro activity of tomopenem(CS-023)against Methicillin-resistant Staphylococ-cus aureus and Pseudomonas aeruginosa[J].Antimicrob Agents Chemother,2008,52(8):2849-2854.
[13]Wang J,Soisson SM,Young K,et al.Platensimycin is a selec-tive FabF inhibitor with potent antibiotic properties[J].Nat,2006,441(18):358-361.
[14]Wang J,Kodali S,Lee SH,et al.Discovery of platencin,a dual FabF and FabH inhibitor with in vivo antibiotic properties[J].Proc Nat Acad Sci USA,2007,104(18):7612-7616.
[15]Tabarez MR,Jansen R,Sylla M,et al.7-O-Malonyl Macrolac-tin A,a new macrolactin antibiotic from bacillus subtilis active a-gainst Methicillin-resistant Staphylococcus aureus,Vancomycin-resistant Enterococci,and a small-colony variant of Burkholderia cepacia[J].Antimicrob agents Chemother,2006,50(5):1701-1709.
[16]Jakeman DL,Bandi S,Graham CL,et al.Antimicrobial activi-ties of Jadomycin B and structurally related analogues[J].Anti-microb Agents Chemother,2009,53(3):1245-1247.
[17]Cegelski L,Marshall GR,Eldridge GR,et al.The biology and future prospects of antivirulence therapies[J].Nat Rev Microbi-ol,2008,6(1):17-27.
[18]Liu GY,Essex A,Buchanan JT,et al.Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity[J].J Exp Med,2005,202(2):209-215.
[19]Liu CI,Liu GY,Song YC,et al.A cholesterol biosynthesis in-hibitor blocks Staphylococcus aureus virulence[J].Sci,2008,319(7):1391-1394.
[20]Song YC,Liu CI,Lin FY,et al.Inhibition of Staphyloxanthin virulence factor biosynthesis in Staphylococcus aureus:in vitro,and crystallographic results[J].J Med Chem,2009,52(13):3869-3880.
[21]Maresso AW,Schneewind O.Sortase as a target of anti-infec-tive therapy[J].Pharmacol Rev,2008,60(1):128-141.
[22]Kudryavtsev KV,Bentley ML,McCafferty DG.Probing of the cis-5-phenyl proline scaffold as a platform for the synthesis of mech-anism-based inhibitors of the Staphylococcus aureus sortase SrtA isoform[J].Bioorg Med Chem,2009,17:2886-2893.
[23]Brown S,Zhang YH,Walker S.A revised pathway proposed for Staphylococcus aureus wall teichoic acid biosynthesis based on in vitro reconstitution of the intracellular steps[J].Chembiol,2008,15:15-21.
【关闭】
